A good screening tool seems to offer the best hope, but meanwhile best possible care includes definitive staging and surgery by experienced specialist teams
Ovarian cancer is the leading cause of death from gynaecological cancer in Australia, and indeed most Western countries. In the absence of effective primary prevention strategies and screening for early disease, the best possible management of patients with suspected or established ovarian cancer assumes critical importance if inroads are to be made in reducing morbidity and mortality from this disease.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Hunter Centre for Gynaecological Cancer, John Hunter Hospital, Newcastle, NSW.
- 1. Grossi M, Quinn MA, Thursfield VJ, et al. Ovarian cancer: patterns of care in Victoria during 1993–1995. Med J Aust 2002; 177: 11-16. <eMJA full text>
- 2. Carney ME, Lancaster JM, Ford C, et al. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 2002; 84: 36-42.
- 3. Parker J, Proietto AM, Lowe G. Clear cell carcinoma of the ovary in a 19 year old woman. Aust N Z J Obstet Gynaecol 1998; 38: 118-120.
- 4. Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 82: 532-537.
- 5. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: Is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 2001; 82: 435-441.
- 6. Clayton RD, Obermair A, Hammond IG, et al. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002; 84: 53-57.
- 7. van Nagell JR Jr, De Priest PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000; 77: 350-356.